Aging changes biology. Real-time insight helps you stay ahead.
As we age, our risk of cancer increases. This is not just about family history or lifestyle it’s also about natural changes in how our cells function. Subtle molecular signals can shift long before symptoms or imaging findings appear.
The miRoncol Real-time Multi-Cancer Early Risk Assessment provides a snapshot of your current molecular biology, helping you and your physician make more informed decisions about prevention and follow-up.
Why It Matters
- Cancer risk rises with age — nearly half of cancers occur in people over 65.
- Conventional screening is often age-based, but only applies to a few cancer types.
- Molecular signals, like microRNAs, may shift earlier, reflecting evolving biology as we get older.
How the Test Helps
- Detects microRNA changes linked to early tumour biology across 12+ common solid tumours.
- Provides real-time insight that evolves as your biology changes.
- Complements existing age-related screenings like mammography, colonoscopy, or PSA (when recommended by your physician).
Benefits for Aging & Prevention-Focused Individuals
- Provide peace of mind particularly with increased risk of cancer due to aging
- Offers reassurance and peace of mind between standard screenings
- Can be repeated over time for longitudinal monitoring
- Complements longevity, wellness, and executive health programs
How It Fits Into Preventive Care
- Add to your annual checkups or executive health assessments
- Use alongside lifestyle and longevity programs to measure the impact of interventions on molecular health
- Provides a biological perspective today that genetic or lifestyle assessments alone cannot offer
Limitations & Ethics
The test is not diagnostic and does not replace conventional screenings. Instead, it provides molecular-level insight designed to support physician-led decision-making about earlier or more frequent follow-up.
Next Step
Aging is inevitable but proactive cancer prevention is within your control. By monitoring biological signals in real time, cancers can be detected earlier, when more options are available, lives can be saved, and quality of life can be preserved.
